➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
Johnson and Johnson
Merck
Mallinckrodt
Harvard Business School

Last Updated: October 18, 2021

DrugPatentWatch Database Preview

EFINACONAZOLE Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

DrugPatentWatch® Litigation and Generic Entry Outlook for Efinaconazole

A generic version of EFINACONAZOLE was approved as efinaconazole by TEVA PHARMS USA on December 16th, 2020.

  Free Forever Trial

Drug patent expirations by year for EFINACONAZOLE
Recent Clinical Trials for EFINACONAZOLE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Dong-A ST Co., Ltd.Phase 4
Western University of Health SciencesPhase 3
Valeant Pharmaceuticals International, Inc.Phase 4

See all EFINACONAZOLE clinical trials

Paragraph IV (Patent) Challenges for EFINACONAZOLE
Tradename Dosage Ingredient NDA Submissiondate
JUBLIA SOLUTION;TOPICAL efinaconazole 203567 2018-06-06

US Patents and Regulatory Information for EFINACONAZOLE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Acrux Dds EFINACONAZOLE efinaconazole SOLUTION;TOPICAL 211969-001 Jun 21, 2021 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Teva Pharms Usa EFINACONAZOLE efinaconazole SOLUTION;TOPICAL 211827-001 Dec 16, 2020 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Aurobindo Pharma Ltd EFINACONAZOLE efinaconazole SOLUTION;TOPICAL 212066-001 Mar 29, 2021 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Padagis Us EFINACONAZOLE efinaconazole SOLUTION;TOPICAL 211851-001 Dec 16, 2020 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
Johnson and Johnson
Merck
Mallinckrodt
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.